Aktiesnakken — Marts 2010
-
jeg tror analytikerne måske er overrasket over at der måske kan files på data
-
nu lidt versus erbitux
-
ikke noget med sideeffects, ser stadig bedre end erbitux
-
nothing to woory about here, compliments from the dutch dealer
-
we are not in a position to discuss per protokol
-
hvornår kommer frank mon på banen?
-
er der higher dose planned. Det er highest dose. 60% går på højeste dose
-
individual dosing er en very clever idea. Ja Granberg hvis man møder sine endpoints
-
ellers er det bare stupidt at fremhæve at man har fejlet på den smarte måde
-
we dont look forward to speaking with you lisa. It costs a billion kroner each time
man keder sig aldrig med Lisa
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind